Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s ...
2-Year U.S. Treasury Note Continuous Contract $103.766-0.004 0.00% 5-Year U.S. Treasury Note Continuous Contract $108.281 0.164 0.15% 10-Year U.S. Treasury Note Continuous Contract $111.234 0.016 0.01 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results